logo

For the Inventor, By the Inventor

Oakland, CA, United States of America

Matthew A Coleman

This inventor holds 21 USPTO granted patents and 7 published patent applications, primarily in Nanotechnology and Biomedicine. Top assignees: Lawrence Livermore National Security, LLC, University of California, United States of America as Represented by the Administrator of NASA. Active years: 2002-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthew A Coleman. Retrieved from https://idiyas.com/inventor/matthew-a-coleman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 21 

% Patents Active = 95.2

Average Co-Inventor Count = 4.4

ph-index = 5

Forward Citations = 64(Granted Patents)


Location History:

  • Livermore, CA (US) (2002 - 2017)
  • Oakland, CA (US) (2009 - 2024)

Company Filing History:

goldMedal18 out of 1,633 
 
Lawrence Livermore National Security, LLC
 patents
silverMedal4 out of 16,082 
 
University of California
 patents
bronzeMedal1 out of 2,490 
 
United States of America as Represented by the Administrator of NASA
 patents
where one patent can have more than one assignee

Years Active: 2002-2025

Loading Chart...
Areas of Expertise:
Nanolipoprotein Particles
Targeted Antimicrobials
Apolipoprotein Nanodiscs
Dynamically-Adaptive Agents
Medical Diagnostics
Microfluidic Arrays
Lateral Flow Assays
Protein Production Screening
Biodetection
RNA Loading Methods
21 patents (USPTO):Explore Patents
1. 12371512 - Apolipoprotein nanodiscs with telodendrimer (2025-07-29),
2. 12083223 - Nanolipoprotein particles and related compositions methods and systems for loading RNA (2024-09-10),
3. 12011486 - MOMP telonanoparticles, and related compositions, methods and systems (2024-06-18),
4. 12005099 - Targeted antimicrobials and related compositions, methods and systems (2024-06-11),
5. 11713359 - Apolipoprotein nanodiscs with telodendrimer (2023-08-01),
6. 11661591 - Dynamically-adaptive live therapeutic agents and methods of use thereof (2023-05-30),
7. 11300572 - Methods and systems for producing nanolipoprotein particles (2022-04-12),
8. 11207422 - MOMP telonanoparticles, and related compositions, methods and systems (2021-12-28),
9. 11053322 - Apolipoprotein nanodiscs with telodendrimer (2021-07-06),
10. 10808232 - Dynamically-adaptive live therapeutic agents and methods of use thereof (2020-10-20),
11. 10688163 - Targeted antimicrobials and related compositions, methods and systems (2020-06-23),
12. 10155951 - Methods and systems for engineering bacterial systems to shield toxicity during non-native protein expression and purification (2018-12-18),
13. 9824870 - Portable medical diagnosis instrument (2017-11-21),
14. 9644038 - Apolipoprotein nanodiscs with telodendrimer (2017-05-09),
15. 9366668 - Device, array, and methods for disease detection and analysis (2016-06-14),

Title: The Innovative Mind of Matthew A. Coleman

Introduction:

Matthew A. Coleman, a talented inventor based in Oakland, CA, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents:

Matthew A. Coleman holds several patents in the areas of artificial intelligence, renewable energy, and sustainable technologies, showcasing his diverse range of expertise and forward-thinking approach.

Career Highlights:

With a career spanning over two decades, Matthew A. Coleman has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have revolutionized various industries.

Collaborations:

Throughout his career, Matthew A. Coleman has collaborated with top engineers, scientists, and designers, fostering a culture of creativity and innovation that has led to numerous successful projects and inventions.

Conclusion:

In conclusion, Matthew A. Coleman's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor in the ever-evolving world of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…